Skip to content
Events

Person in hazmat suit producing radiopharmaceuticals

Meet Team Norway at EANM 2026

17.10.2026 - 21.10.2026

Location: Austria Center, Wien, Austria

Exhibition

Norway is investing heavily in nuclear medicine and radiopharmaceuticals — and it shows. Meet the companies shaping Europe’s next generation of diagnostics and targeted therapies at EANM 2026.

EANM is Europe’s premier congress for nuclear medicine and molecular imaging, bringing together clinicians, researchers and industry leaders from across the globe. It’s a prime arena to highlight Norway’s accelerating capabilities in imaging, precision diagnostics and therapy innovation.

More information about Team Norway activities will follow.
Reach out if you’re exploring collaboration in nuclear medicine or radiopharma.

Contact us

Maria C. Lundstad Aulie

Investment Manager | Greater Oslo region

Health and life science

Send email

Organisers

logo of INNOVATION NORWAY

INNOVATION NORWAY

Website

logo of NORTRIALS

NORTRIALS

Website

Important conditions

Companies must adhere to standards for responsible business conduct, including Environmental, Social, and Governance (ESG) criteria.

Participants are expected to operate in accordance with the UN Guiding Principles on Business and Human Rights and the OECD Guidelines for Multinational Enterprises on Responsible Business Conduct. This entails conducting business responsibly, respecting human rights, ensuring decent working conditions, safeguarding environmental considerations, and actively preventing corruption.

Companies must carry out their own due diligence assessments (risk assessments) to identify, prevent, and mitigate potential adverse impacts.